Literature DB >> 21715027

Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children.

J Madana1, Deeke Yolmo, R Kalaiarasi, S Gopalakrishnan, S Sujatha.   

Abstract

INTRODUCTION: Chronic suppurative otitis media (CSOM) is the most common cause of childhood hearing impairment in the developing countries and atticoantral type is associated with increased incidence of intracranial and extracranial complications. This study was undertaken to define the microbiology of atticoantral type of chronic otitis media and the antibiotic sensitivity pattern, thereby reducing the potential risks of complications.
MATERIALS AND METHODS: A retrospective study was done in the Department of Otolaryngology, JIPMER, Puducherry from the year August 2003 to October 2009 using the medical record department database to retrieve the patient details. During this study period, 223 children with atticoantral type CSOM consisting of 126 males and 97 females with an age range of 1-14 years were assessed. Patients with persistent otorrhea for more than 3 months with atticoantral type of chronic otitis media were selected. The exudates were collected under sterile conditions and inoculated onto culture media; bacterial growth and antibiotic sensitivity pattern were studied.
RESULTS: Nine species of micro organisms were isolated from the middle ear aspirate, Pseudomonas aeruginosa being the most predominant isolate constituting about 32% (72 discharging ears) of the total isolates followed by Proteus mirabilis (20% of isolates) and Staphylococcus aureus (19% of isolates). Gram negative organisms accounted 58% of total isolates and gram positive organisms constituted 22% isolates. Candida albicans and methicillin resistant S. aureus were identified in 4% and 2% of isolates, respectively. 100% of Pseudomonas isolates showed susceptibility to ceftazidime and a high sensitivity (92% of isolates) to ciprofloxacin and 88% isolates were sensitive to amikacin. 100% of P. mirabilis isolated from inoculates showed sensitivity to ceftazidime and ciprofloxacin. It also showed 87-97% sensitivity to ceftriaxone, amikacin and ampicillin. All (100%) of the Staphylococcus isolates were sensitive to vancomycin and 84-86% were sensitive to ciprofloxacin and erythromycin. In general, gram negative organisms showed increased sensitivity to ceftazidime, ciprofloxacin and amikacin, while gram positive organisms to vancomycin, erythromycin and ciprofoxacin.
CONCLUSION: Continuous and periodic evaluation of microbiological pattern and antibiotic sensitivity of cholesteatomatous CSOM is necessary to decrease the potential risks of complications by early institution of appropriate systemic and topical antibiotic alongside mastoid exploration. We believe that our data may contribute to an effective medical management of chronic suppurative otitis media with cholesteatoma. Since the most common organisms in our clinical set up being P. aeruginosa, P. mirabilis and S. aureus, which showed a percentage susceptibility of 100% to ceftazidime and vancomycin, thus making it an empirical antibiotic combination therapy of choice in the recent times. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715027     DOI: 10.1016/j.ijporl.2011.05.025

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  17 in total

1.  Topical treatment of chronic suppurative otitis media.

Authors:  Sam J Daniel
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

2.  Nasal Colonization of Methicillin-Resistant Staphylococcus aureus in Patients with Chronic Suppurative Otitis Media.

Authors:  Eun Jung Lee; Jin Ho Kwon; Ah Young Park; Won-Sang Lee; Eun Jin Son
Journal:  Korean J Audiol       Date:  2012-09-20

3.  Highly biocompatible behaviour and slow degradation of a LDH (layered double hydroxide)-coating on implants in the middle ear of rabbits.

Authors:  Franziska Duda; Marc Kieke; Florian Waltz; Maria E Schweinefuß; Muhammad Badar; Peter Paul Müller; Karl-Heinz Esser; Thomas Lenarz; Peter Behrens; Nils Kristian Prenzler
Journal:  J Mater Sci Mater Med       Date:  2015-01-11       Impact factor: 3.896

4.  Layered double hydroxides as efficient drug delivery system of ciprofloxacin in the middle ear: an animal study in rabbits.

Authors:  Daniela Hesse; Muhammad Badar; André Bleich; Anna Smoczek; Silke Glage; Marc Kieke; Peter Behrens; Peter Paul Müller; Karl-Heinz Esser; Martin Stieve; Nils Kristian Prenzler
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

5.  Chronological changes in microbial profiles in external and middle ear diseases: a 20-year study in Korea.

Authors:  Hantai Kim; Oak-Sung Choo; Jeong Hun Jang; Hun Yi Park; Yun-Hoon Choung
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-23       Impact factor: 2.503

6.  Inactivation of specific Pseudomonas aeruginosa biofilm factors does not alter virulence in infected cholesteatomas.

Authors:  Richard A Chole; Patricia M Gagnon; Joseph P Vogel
Journal:  Otol Neurotol       Date:  2014-10       Impact factor: 2.311

Review 7.  Role of innate immunity in the pathogenesis of otitis media.

Authors:  Rahul Mittal; Joyson Kodiyan; Robert Gerring; Kalai Mathee; Jian-Dong Li; M'hamed Grati; Xue Zhong Liu
Journal:  Int J Infect Dis       Date:  2014-11-05       Impact factor: 3.623

8.  Determinants of non-healing ear discharge in chronic suppurative otitis media in a developing country.

Authors:  Foster Tochukwu Orji; Benjamin O Dike; Onuoha Oji
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-02       Impact factor: 2.503

9.  FleQ, a Transcriptional Activator, Is Required for Biofilm Formation In Vitro But Does Not Alter Virulence in a Cholesteatomas Model.

Authors:  Wee Tin K Kao; Patricia M Gagnon; Joseph P Vogel; Richard A Chole
Journal:  Otol Neurotol       Date:  2016-08       Impact factor: 2.311

Review 10.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.